ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 176 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.55 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $204,898 | -68.5% | 41,227 | +63.1% | 0.00% | -66.7% |
| Q3 2021 | $650,000 | -18.3% | 25,283 | -17.1% | 0.00% | -25.0% |
| Q2 2021 | $796,000 | -32.9% | 30,513 | -9.2% | 0.00% | -20.0% |
| Q1 2021 | $1,186,000 | +6.3% | 33,600 | -24.0% | 0.01% | 0.0% |
| Q4 2020 | $1,116,000 | -34.4% | 44,235 | -2.0% | 0.01% | -37.5% |
| Q3 2020 | $1,702,000 | -18.1% | 45,135 | -7.0% | 0.01% | -20.0% |
| Q2 2020 | $2,079,000 | – | 48,555 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $5,700,177 | 8.82% |
| Wildcat Capital Management, LLC | 1,920,787 | $6,088,895 | 2.44% |
| TPG GP A, LLC | 18,716,306 | $59,330,690 | 1.02% |
| EcoR1 Capital, LLC | 4,488,200 | $14,227,594 | 0.48% |
| CROSSPOINT FINANCIAL, LLC | 12,000 | $38,040 | 0.40% |
| Coastal Bridge Advisors, LLC | 406,847 | $1,289,705 | 0.35% |
| CAXTON ASSOCIATES LP | 480,104 | $1,521,930 | 0.21% |
| Woodline Partners LP | 5,313,915 | $16,845,111 | 0.20% |
| Rhenman & Partners Asset Management AB | 300,000 | $951,000 | 0.10% |
| Navalign, LLC | 75,365 | $238,907 | 0.09% |